Fintel reports that on October 20, 2025, D. Boral Capital upgraded their outlook for CorMedix (NasdaqGM:CRMD) from Hold to Buy.
Analyst Price Forecast Suggests 71.96% Upside
As of September 30, 2025, the average one-year price target for CorMedix is $20.91/share. The forecasts range from a low of $17.17 to a high of $24.15. The average price target represents an increase of 71.96% from its latest reported closing price of $12.16 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for CorMedix is 1,288MM, an increase of 960.22%. The projected annual non-GAAP EPS is -0.78.
What is the Fund Sentiment?
There are 315 funds or institutions reporting positions in CorMedix. This is an increase of 53 owner(s) or 20.23% in the last quarter. Average portfolio weight of all funds dedicated to CRMD is 0.10%, an increase of 136.73%. Total shares owned by institutions increased in the last three months by 41.81% to 40,654K shares. 
The put/call ratio of CRMD is 0.35, indicating a bullish outlook.
What are Other Shareholders Doing?
Marshall Wace, Llp holds 2,580K shares representing 3.31% ownership of the company. In its prior filing, the firm reported owning 231K shares , representing an increase of 91.06%. The firm increased its portfolio allocation in CRMD by 1,885.89% over the last quarter.
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 2,393K shares representing 3.07% ownership of the company. In its prior filing, the firm reported owning 1,979K shares , representing an increase of 17.31%. The firm increased its portfolio allocation in CRMD by 115.80% over the last quarter.
Citadel Advisors holds 1,714K shares representing 2.20% ownership of the company. In its prior filing, the firm reported owning 106K shares , representing an increase of 93.82%. The firm increased its portfolio allocation in CRMD by 2,862.06% over the last quarter.
IWM - iShares Russell 2000 ETF holds 1,597K shares representing 2.05% ownership of the company. In its prior filing, the firm reported owning 1,619K shares , representing a decrease of 1.37%. The firm increased its portfolio allocation in CRMD by 99.19% over the last quarter.
Geode Capital Management holds 1,596K shares representing 2.05% ownership of the company. In its prior filing, the firm reported owning 1,433K shares , representing an increase of 10.24%. The firm increased its portfolio allocation in CRMD by 98.63% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
